BCI
DCPH

Brinker Capital Investments’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Brinker Capital Investments’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,460
Closed -$369K – 1290
2020
Q4 		$369K Buy
+6,460
New +$383K 0.01% 898

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brinker Capital Investments's DCPH Position: Q1 2021 in Review

Brinker Capital Investments sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2021, closing a stake of 6,460 shares — an estimated $369K sold.

Brinker Capital Investments first reported a position in DCPH in Q4 2020 and held it in 1 quarter. The position peaked at $369K in Q4 2020. 167 funds tracked by Wall St. Rank hold DCPH as of Q1 2021.

  • Brinker Capital Investments reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Brinker Capital Investments sold 6,460 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $369K.
  • Brinker Capital Investments first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Brinker Capital Investments's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $369K in Q4 2020.
  • 167 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Brinker Capital Investments's 13F filing for Q1 2021, filed 12 May 2021.